How Pharmac stole my holiday

16 January 2017 - Earlier this month I went to the chemist and got a new prescription filled to take ...

Read more →

Breast cancer patients' distress at withdrawal of Kadcyla

16 January 2017 - Terminal breast cancer patients have spoken of their distress after learning that a life-extending drug they ...

Read more →

SMC - January 2017 decisions

16 January 2017 - The Scottish Medicines Consortium has today published advice accepting four new medicines for routine use in ...

Read more →

Pause on NICE’s cost recovery plans

16 January 2017 - Plans for NICE to recover the costs of its appraisals of drugs, medical devices and diagnostics, ...

Read more →

Health minister vows to save Canadians 'billions' on drug prices

13 January 2017 - Analysis shows Canadians pay substantially more for pharmaceuticals made by Canadian company. ...

Read more →

Rare public hearing highlights concerns over explosion of high-priced specialty drugs in Canada

16 January 2017 - Matt George remembers vividly how it felt to receive his first infusion of Soliris, a drug ...

Read more →

‘Precision medicine’ promises new hope for cancer sufferers

17 January 2017 - A shift from mass to personalised medicine promises new hope for cancer sufferers and health authorities, ...

Read more →

Health insurance premiums set to rise

16 January 2017 - Australian families could soon be forking out an extra $200 for private health cover as insurers ...

Read more →

Private health insurance nears crisis point as costs soar

14 January 2017 - Health insurance chiefs have warned that the issue of affordability is close to crisis point as ...

Read more →

Pharmacists get power to alter prescriptions under controversial trial

11 January 2017 - Pharmacists will have the power to alter prescriptions for patients with chronic conditions like asthma in ...

Read more →

Additional listings on the Pharmaceutical Schedule of a range of orthopaedic joint implants, additional CMF implants, associated products and bone cement with Stryker

12 January 2017 - PHARMAC is pleased to announce the approval of an amendment to the trauma, spine and CMF ...

Read more →

NICE approves kidney cancer drug for NHS use

12 January 2017 - Patients with advanced kidney cancer will have routine NHS access to the drug everolimus following recommendations by ...

Read more →

Aussie pharmaceuticals whacked by Donald Trump

12 January 2017 - Australian health stocks took an early hit on the local market following US president elect Donald ...

Read more →

NICE publishes final guidance on the use of Keytruda for non-small-cell lung cancer

11 January 2017 - The guidance relates to the use of Keytruda (pembrolizumab) for treating PD-L1-positive non-small-cell lung cancer in adults ...

Read more →

AbbVie withdraws submission for Venclexta

10 January 2017 - Abbvie was seeking funding for venetoclax when used as a treatment for patients with chronic lymphocytic ...

Read more →